CONCOURSE FINANCIAL GROUP SECURITIES, INC. - CHECKMATE PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 1 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
CONCOURSE FINANCIAL GROUP SECURITIES, INC. ownership history of CHECKMATE PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$0–0–0.00%–
Q4 2021$0–0–0.00%–
Q3 2021$0–0–0.00%–
Q2 2021$0–0–0.00%–
Q1 2021$0–0–0.00%–
Q4 2020$0–0–0.00%–
Q3 2020$0–0–0.00%–
 Download
Other shareholders
CHECKMATE PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 0$00.00%
View complete list of CHECKMATE PHARMACEUTICALS IN shareholders